- Home
- EDBL vs SILO Comparison
EDBL vs SILO Comparison
Compare EDBL & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- SILO
- Stock Information
- Founded
- EDBL 2020
- SILO 2010
- Country
- EDBL United States
- SILO United States
- Employees
- EDBL N/A
- SILO N/A
- Industry
- EDBL Farming/Seeds/Milling
- SILO Apparel
- Sector
- EDBL Consumer Staples
- SILO Consumer Discretionary
- Exchange
- EDBL Nasdaq
- SILO Nasdaq
- Market Cap
- EDBL 3.2M
- SILO 4.9M
- IPO Year
- EDBL 2022
- SILO N/A
- Fundamental
- Price
- EDBL $0.21
- SILO $1.20
- Analyst Decision
- EDBL
- SILO
- Analyst Count
- EDBL 0
- SILO 0
- Target Price
- EDBL N/A
- SILO N/A
- AVG Volume (30 Days)
- EDBL 1.3M
- SILO 73.6K
- Earning Date
- EDBL 11-11-2024
- SILO 11-14-2024
- Dividend Yield
- EDBL N/A
- SILO N/A
- EPS Growth
- EDBL N/A
- SILO N/A
- EPS
- EDBL N/A
- SILO N/A
- Revenue
- EDBL $14,774,000.00
- SILO $72,102.00
- Revenue This Year
- EDBL $14.19
- SILO $1.86
- Revenue Next Year
- EDBL $27.76
- SILO N/A
- P/E Ratio
- EDBL N/A
- SILO N/A
- Revenue Growth
- EDBL 18.14
- SILO N/A
- 52 Week Low
- EDBL $0.19
- SILO $0.84
- 52 Week High
- EDBL $13.40
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- EDBL 17.27
- SILO 58.41
- Support Level
- EDBL $0.19
- SILO $1.00
- Resistance Level
- EDBL $0.22
- SILO $1.08
- Average True Range (ATR)
- EDBL 0.02
- SILO 0.06
- MACD
- EDBL 0.02
- SILO 0.03
- Stochastic Oscillator
- EDBL 23.00
- SILO 94.21
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.